An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
Обновлённые рекомендации Европейского общества по клиническим и экономическим аспектам остеопороза, остеоартрита и заболеваний опорно-двигательного аппарата (ESCEO) в отношении алгоритма ведения пациентов с остеоартритом коленного сустава
2019-04-30
SCID: 54.1/jxjzgyh2
Discuss with AI
ESCEO algorithmGRADE processknee osteoarthritisnon-pharmacological interventionsstepwise treatment algorithm
Figures from the paper
Abstract (AI)
OBJECTIVES: The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) sought to revisit the 2014 algorithm recommendations for knee osteoarthritis (OA), in light of recent efficacy and safety evidence, in order to develop an updated stepwise algorithm that provides practical guidance for the prescribing physician that is applicable in Europe and internationally. METHODS: Using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) process, a summary of evidence document for each intervention in OA was provided to all members of an ESCEO working group, who were required to evaluate and vote on the strength of recommendation for each intervention. Based on the evidence collected, and on the strength of recommendations afforded by consensus of the working group, the final algorithm was constructed. RESULTS: An algorithm for management of knee OA comprising a stepwise approach and incorporating consensus on 15 treatment recommendations was prepared by the ESCEO working group. Both "strong" and "weak" recommendations were afforded to different interventions. The algorithm highlights the continued importance of non-pharmacological interventions throughout the management of OA. Benefits and limitations of different pharmacological treatments are explored in this article, with particular emphasis on safety issues highlighted by recent literature analyses. CONCLUSIONS: The updated ESCEO stepwise algorithm, developed by consensus from clinical experts in OA and informed by available evidence for the benefits and harms of various treatments, provides practical, current guidance that will enable clinicians to deliver patient-centric care in OA practice.
Key Findings
1
ESCEO updated its 2014 knee osteoarthritis management algorithm using GRADE evidence assessment and expert consensus.
2
Pharmacological options are evaluated according to their benefits, limitations, and safety concerns identified in recent evidence analyses.
3
The algorithm emphasizes that non-pharmacological interventions should remain important throughout knee osteoarthritis management.
4
The resulting stepwise algorithm incorporates consensus on 15 treatment recommendations, with interventions receiving either strong or weak recommendation strength.
5
The updated algorithm provides practical, current, and patient-centered guidance for clinicians managing knee osteoarthritis in Europe and internationally.
Research Object
knee osteoarthritis management
Research Subject
an updated stepwise treatment algorithm based on the efficacy, safety, and strength of recommendations for pharmacological and non-pharmacological interventions
Publication Details
Publication Date
2019-04-30
Journal
Publisher
ISSN
Cited by
753
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai6
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations2008
American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee2012
Effect of Opioid vs Nonopioid Medications on Pain-Related Function in Patients With Chronic Back Pain or Hip or Knee Osteoarthritis Pain: The SPACE Randomized Clinical Trial2018
An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: A report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)2014
Pharmaceutical-grade Chondroitin sulfate is as effective as celecoxib and superior to placebo in symptomatic knee osteoarthritis: the ChONdroitin versus CElecoxib versus Placebo Trial (CONCEPT)2017
Safety of Symptomatic Slow-Acting Drugs for Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis2019
Cited by4
Targeted and responsive biomaterials in osteoarthritis2023
Efficacy of combined use of glycosaminoglycan peptide complex for intramuscular administration and oral diacerein in osteoarthritis: evaluation according to an observational multicenter clinical trial2021
Evaluation of the efficacy and safety of injectable glycosaminoglycan-peptide complex (GPC) in patients with osteoarthritis: a multicenter observational study GLADIOLUS (GPC in the treatment of osteoarthritis: a follow-up study of pain relief and local symptom reduction)2020
EFFECTIVENESS AND SAFETY OF CONCOMITANT USE OF PEPTIDE COMPLEX AND DIACEREIN IN OSTEOARTHRITIS OF KNEE JOINT2022